Steve is a seasoned professional with over 30 years of experience providing strategic guidance to biotech and pharmaceutical clients to help them navigate complex market dynamics. He has successfully led numerous notable product launches by consistently demonstrating the inherent value of innovative therapies. He is also known for his ability to build highly skilled and motivated teams to tackle the challenges of market access and distribution and develop effective solutions to drive success in the ever-evolving field of life sciences.
As President of Petauri Advisors, Steve's priorities are to build a world- class practice of industry veterans to help clients demonstrate the value of their technologies in a dynamic and constantly changing landscape. To accomplish these objectives, Steve will leverage extensive and deep industry relationships. Additionally, he will introduce cross-functional resources, including health economics, medical affairs, and data and analytics, to provide a comprehensive and cohesive range of services to clients.
Steve enjoys working in the start-up environment. Over the past 3 decades, he has successfully established multiple market access teams, from the ground up, within the worlds of pharma and consulting. Steve feels fortunate to have had the opportunity to grow his market access expertise at Amylin Pharmaceuticals and Vertex Pharmaceuticals, becoming the head of market access, successively, at both companies. His tenures at Amylin and Vertex included significant launches within HCV and diabetes, respectively. Steve leveraged the skills gained in those roles to form the Payer Engagement team at PriceSpective, which was acquired by ICON. In 2015, he became President of MKO Global Partners.
